Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $207.9 million versus the consensus estimate of $204.97 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q3 2023 revenue of $217-222 million, versus the consensus of $214 million.

Hims & Hers Health, Inc. sees FY2023 revenue of $830-850 million, versus the consensus of $831 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.